1文献来源
Kantarjian HM ,Thomas XG, Dmozynska A, et al. Muhicenter, randomized, open-label, phase Ⅲ trial of Decitabine versus patient choice, with physician advice, of either supportive care or low-dose Cytarabine...1文献来源
Kantarjian HM ,Thomas XG, Dmozynska A, et al. Muhicenter, randomized, open-label, phase Ⅲ trial of Decitabine versus patient choice, with physician advice, of either supportive care or low-dose Cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia [J]. J Clin Oncol, 2012,30（21 ） ：2670-2677.展开更多
文摘1文献来源
Kantarjian HM ,Thomas XG, Dmozynska A, et al. Muhicenter, randomized, open-label, phase Ⅲ trial of Decitabine versus patient choice, with physician advice, of either supportive care or low-dose Cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia [J]. J Clin Oncol, 2012,30（21 ） ：2670-2677.
